DREDGECAP
← IDXX OverviewCompare dilution across companies →

Is IDXX diluting shareholders? — Share Count Reducing

IDEXX LABORATORIES INC /DE's share count has DECREASED by 5.49% over the last ~49 months — likely a buyback program or share consolidation. Existing shareholders' percentage ownership is rising rather than falling.

Growth Rate
-5.49%
~49 months
Current Shares
79.6M
2026-02-13
ATM Facility
Not detected
Convertible Notes
Not detected
Reverse Split
Not detected

Share-Count History — From IDXX Annual Filings

10-K · 2026-02-1379,624,034 shares
10-K · 2025-02-1281,328,233 shares
10-K · 2024-02-1283,089,381 shares
10-K · 2023-02-1082,903,371 shares
10-K · 2022-02-1184,249,085 shares

What Dilution Means for IDXX Shareholders

Dilution refers to the reduction in existing shareholders' percentage ownership when a company issues new shares. Companies dilute for multiple legitimate reasons — funding growth, acquiring other companies, compensating employees with equity, or converting debt to equity. Whether dilution is good or bad depends on what the new capital is being used for and whether per-share value grows faster than the share count. For IDEXX LABORATORIES INC /DE, share count went from 84,249,085 on 2022-02-11 to 79,624,034 on 2026-02-13 — a change of -5.49% over approximately 49 months.

The dilution mechanism shareholders should monitor most closely is the presence of an ATM (at-the-market) equity facility. ATMs give the company standing authority to issue new shares into the open market at any time, often without separate shareholder notice. They create continuous-issuance overhang — even days when no new shares are sold, the facility itself weighs on the stock as supply might appear at any moment. IDEXX LABORATORIES INC /DE's most recent annual filing does not mention an ATM facility — though that status can change with each new financing round.

Convertible notes are a separate forward-dilution mechanism: each note converts into shares at a defined price (or formula) at maturity, automatically expanding share count. The presence of large convertible-note balances on the balance sheet — even before conversion — is a material signal that future dilution is contractually scheduled. No convertible notes are mentioned in IDEXX LABORATORIES INC /DE's most recent annual filing.

For broader context on IDXX's risk profile, see the IDXX Overview page. For audit-opinion status, see the Going Concern page.

Disclosure: Share counts are extracted from the cover page of IDXX's cached SEC annual filings. Classification reflects share-count growth rate, presence of an ATM facility, and convertible-note disclosures at the time of the most recent annual filing. Status can change with new financing rounds. This page is not legal or investment advice.